About Unichem Laboratories Limited
Data last updated: 15 July 2026
Unichem Laboratories Limited is a public limited company based in Kandivali West, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 22 August 1962, the company has been in operation for over 64 years.
Registered with ROC Mumbai under CIN L99999MH1962PLC012451. Listed on BSE: 506690 and NSE: UNICHEMLAB.
Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹14.08 Cr. It is led by directors including Prakash Amrut Mody and Swati Arvind Patankar.
Last AGM: 04 August 2025. Financial statements filed for year ended 31 March 2025. Office: 47 Kandivli Industrial Estate, Kandivali West, Maharashtra, India – 400067.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹2,201.85 Cr, a growth of 4.31% compared to the previous year. The net worth stands at ₹2,717.44 Cr (up 10.89% YoY). Total assets are valued at ₹3,737.44 Cr (up 4.71% YoY).
The company has a workforce of approximately 3,635 employees as per the latest available data.
The company is associated with 2 brands - Unichem Laboratories, Unichem Labs. As per MCA filings, the company has open charges of ₹236 Cr and satisfied charges of ₹249.07 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unichemlabs.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address47 Kandivli Industrial Estate, Kandivali West, Maharashtra, India – 400067
-
IndustryPharma, API Manufacturers, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Unichem Laboratories Limited
Unichem Laboratories Limited operates two associated brands: Unichem Laboratories and Unichem Labs. These brands represent Unichem Laboratories Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Branded formulations, APIs, and biosimilars are manufactured. | unichemlabs.com | |
| Pharmaceutical formulations, active pharmaceutical ingredients manufacturing, and related services in India. | unichem-hrp.com |
Business Activity of Unichem Laboratories Limited
Unichem Laboratories Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Unichem Laboratories Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Unichem Laboratories Limited
Unichem Laboratories Limited is audited by N A Shah Associates LLP (ICAI peer reviewed, certificate valid till 2028-08-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| N A Shah Associates LLP (ICAI peer reviewed, certificate valid till 2028-08-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Unichem Laboratories Limited
Unichem Laboratories Limited is currently managed by 6 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prakash Amrut Mody | Director | 01 Jul 2008 | 18 Years 1 Months | Current |
|
Swati Arvind Patankar
Also directs:
Ipca Laboratories Limited
|
Additional Director | 05 Feb 2026 | 0 Years 6 Months | Current |
|
Arun Lalchand Todarwal
Also directs:
Arun Todarwal & Associates Llp, Arun Todarwal & Co Llp, Laxmi Organic Industries Limited and 5 more
|
Director | 05 Feb 2024 | 2 Years 6 Months | Current |
| Anand Trimbak Kusre | Director | 05 Feb 2024 | 2 Years 6 Months | Current |
| Pranay Premchand Godha | Director | 10 Aug 2023 | 3 Years 0 Months | Current |
|
Pabitrakumar Kalipada Bhattacharyya
Also directs:
Krebs Biochemicals And Industries Limited
|
Managing Director | 10 Aug 2023 | 3 Years 0 Months | Current |
Financials of Unichem Laboratories Limited FY 2026 filings available
Unichem Laboratories Limited reported revenue of ₹2,201.85 Cr (up 4.31% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹2,201.85 Cr | ₹2,110.97 Cr | ₹1,704.89 Cr | ₹1,343.02 Cr | ₹1,269.83 Cr | ₹1,235.14 Cr | ₹1,210.62 Cr |
| Other Income | ₹63.06 Cr | ₹35.32 Cr | ₹31.6 Cr | ₹38.52 Cr | ₹47.51 Cr | ₹50.19 Cr | ₹91.31 Cr |
| Total Income | ₹2,264.91 Cr | ₹2,146.29 Cr | ₹1,736.49 Cr | ₹1,381.54 Cr | ₹1,317.34 Cr | ₹1,285.32 Cr | ₹1,301.93 Cr |
| Cost of Materials Consumed | ₹768.83 Cr | ₹888.24 Cr | ₹742.8 Cr | ₹532.2 Cr | ₹456.01 Cr | ₹466.99 Cr | ₹421.43 Cr |
| Purchases of Stock-in-Trade | ₹231.51 Cr | ₹175.78 Cr | ₹91.09 Lakh | ₹1.53 Cr | ₹1.35 Cr | ₹53.52 Lakh | ₹1.04 Cr |
| Changes in Inventories | ₹20.21 Cr | -₹200.35 Cr | -₹79.09 Cr | ₹17.2 Cr | -₹41.53 Cr | -₹88.14 Cr | -₹35.76 Cr |
| Employee Benefit Expense | ₹396.63 Cr | ₹402.21 Cr | ₹393.06 Cr | ₹356.41 Cr | ₹330.49 Cr | ₹306.97 Cr | ₹273.28 Cr |
| Finance Costs | ₹31.59 Cr | ₹21.03 Cr | ₹22.66 Cr | ₹17.31 Cr | ₹6.11 Cr | ₹5.12 Cr | ₹7.85 Cr |
| Depreciation & Amortisation | ₹125.12 Cr | ₹124.56 Cr | ₹113.24 Cr | ₹113.44 Cr | ₹91.17 Cr | ₹84.36 Cr | ₹81.67 Cr |
| Other Expenses | ₹600.5 Cr | ₹580.23 Cr | ₹546.96 Cr | ₹481.24 Cr | ₹450.72 Cr | ₹457.67 Cr | ₹601.44 Cr |
| Total Expenses | ₹2,174.39 Cr | ₹1,991.7 Cr | ₹1,740.55 Cr | ₹1,519.33 Cr | ₹1,294.31 Cr | ₹1,233.5 Cr | ₹1,350.96 Cr |
| Profit Before Exceptional Items & Tax | ₹90.52 Cr | ₹154.59 Cr | -₹4.06 Cr | -₹137.8 Cr | ₹23.03 Cr | ₹51.82 Cr | -₹49.02 Cr |
| Exceptional Items | ₹201.86 Cr | ₹0 | -₹57.61 Cr | -₹38.57 Cr | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹292.38 Cr | ₹154.59 Cr | -₹61.67 Cr | -₹176.36 Cr | ₹23.03 Cr | ₹51.82 Cr | -₹49.02 Cr |
| Total Tax Expense | ₹39.54 Cr | ₹17.07 Cr | ₹8.81 Cr | ₹25.86 Cr | -₹11.09 Cr | ₹17.15 Cr | ₹11.97 Cr |
| Net Profit | ₹252.84 Cr | ₹137.52 Cr | -₹70.47 Cr | -₹202.23 Cr | ₹33.06 Cr | ₹34.32 Cr | -₹60.18 Cr |
| attributable to Owners | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 |
| attributable to NCI | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹11.99 Cr | -₹6.97 Cr | -₹5.47 Cr | ₹45.92 Cr | ₹53.75 Cr | ₹16.39 Cr | ₹3.06 Cr |
| Total Comprehensive Income | ₹264.83 Cr | ₹130.55 Cr | -₹75.95 Cr | -₹156.3 Cr | ₹86.81 Cr | ₹50.72 Cr | -₹57.13 Cr |
| EBITDA (computed) | ₹247.23 Cr | ₹300.18 Cr | ₹131.84 Cr | -₹7.04 Cr | ₹120.3 Cr | ₹141.3 Cr | ₹40.49 Cr |
| Basic EPS | ₹35.91 | ₹19.53 | ₹-10.01 | ₹-28.72 | ₹4.70 | ₹4.88 | ₹-8.55 |
| Diluted EPS | ₹35.85 | ₹19.47 | ₹-10.01 | ₹-28.72 | ₹4.68 | ₹4.88 | ₹-8.55 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,737.44 Cr | ₹3,569.4 Cr | ₹3,169.34 Cr | ₹3,193.05 Cr |
| Non-current Assets | ₹1,536.85 Cr | ₹1,531.45 Cr | ₹1,471.84 Cr | ₹1,601.17 Cr |
| Current Assets | ₹2,197.34 Cr | ₹2,029.47 Cr | ₹1,694.16 Cr | ₹1,588.47 Cr |
| Property, Plant & Equipment | ₹1,203.7 Cr | ₹1,279.32 Cr | ₹1,194.43 Cr | ₹1,255.12 Cr |
| Inventories | ₹974.97 Cr | ₹988.74 Cr | ₹704.68 Cr | ₹625.23 Cr |
| Trade Receivables | ₹828.58 Cr | ₹778.81 Cr | ₹610.4 Cr | ₹588.62 Cr |
| Cash & Equivalents | ₹289.48 Cr | ₹89.58 Cr | ₹150.91 Cr | ₹183.75 Cr |
| Equity (Net Worth) | ₹2,717.44 Cr | ₹2,450.59 Cr | ₹2,362.42 Cr | ₹2,435.3 Cr |
| Equity Share Capital | ₹14.08 Cr | ₹14.08 Cr | ₹14.08 Cr | ₹14.08 Cr |
| Borrowings (Non-current) | ₹39.12 Cr | ₹60.81 Cr | ₹38.22 Cr | ₹63.65 Cr |
| Borrowings (Current) | ₹429.66 Cr | ₹369.16 Cr | ₹180.93 Cr | ₹233.74 Cr |
| Total Debt (computed) | ₹468.78 Cr | ₹429.97 Cr | ₹219.15 Cr | ₹297.39 Cr |
| Current Liabilities | ₹885.94 Cr | ₹991.97 Cr | ₹707.88 Cr | ₹639.6 Cr |
| Total Liabilities | ₹1,020 Cr | ₹1,118.81 Cr | ₹806.93 Cr | ₹757.74 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹3.64 Cr | -₹7.02 Cr | ₹16.69 Cr | -₹85.09 Cr | -₹259.61 Cr |
| Investing Cash Flow | ₹192.06 Cr | -₹241.23 Cr | ₹50.4 Cr | ₹202.81 Cr | ₹100.12 Cr |
| Financing Cash Flow | ₹1.86 Cr | ₹183.76 Cr | -₹106.31 Cr | -₹81.3 Cr | ₹191.23 Cr |
| Capital Expenditure | ₹123.04 Cr | ₹137.36 Cr | ₹22.55 Cr | ₹44.32 Cr | ₹127 Cr |
| Free Cash Flow (computed) | -₹119.4 Cr | -₹144.38 Cr | -₹5.85 Cr | -₹129.41 Cr | -₹386.61 Cr |
| Dividends Paid | ₹0 | ₹34 Lakh | ₹21.35 Lakh | ₹28.25 Cr | ₹28.36 Cr |
| Net Change in Cash | ₹199.9 Cr | -₹65.17 Cr | -₹32.84 Cr | ₹38.18 Cr | ₹31.74 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹575.12 Cr | ₹521.17 Cr | ₹578.96 Cr | ₹526.6 Cr | ₹587.18 Cr | ₹533.09 Cr | ₹462.16 Cr | ₹446.43 Cr | ₹431.7 Cr | ₹434.38 Cr | ₹415.63 Cr | ₹423.19 Cr |
| Other Income | ₹23.47 Cr | ₹11.8 Cr | ₹20.97 Cr | ₹6.82 Cr | ₹9.25 Cr | ₹13.62 Cr | ₹8.79 Cr | ₹3.86 Cr | ₹6.15 Cr | ₹11.28 Cr | ₹5.54 Cr | ₹8.63 Cr |
| Total Income | ₹598.59 Cr | ₹532.97 Cr | ₹599.93 Cr | ₹533.42 Cr | ₹596.43 Cr | ₹546.71 Cr | ₹470.95 Cr | ₹450.29 Cr | ₹437.85 Cr | ₹445.66 Cr | ₹421.16 Cr | ₹431.82 Cr |
| Cost of Materials Consumed | ₹184.03 Cr | ₹174.26 Cr | ₹193.06 Cr | ₹217.48 Cr | ₹275.31 Cr | ₹175.05 Cr | ₹210.29 Cr | ₹208.06 Cr | ₹197.67 Cr | ₹193.92 Cr | ₹174.94 Cr | ₹176.27 Cr |
| Purchases of Stock-in-Trade | ₹91.81 Cr | ₹48.93 Cr | ₹39.76 Cr | ₹51.01 Cr | ₹33.48 Cr | ₹63.43 Cr | ₹15.2 Cr | ₹27.95 Lakh | ₹21.21 Lakh | ₹21.28 Lakh | ₹24.22 Lakh | ₹24.38 Lakh |
| Changes in Inventories | -₹7.82 Cr | ₹13.91 Cr | ₹37.56 Cr | -₹23.44 Cr | -₹44.22 Cr | -₹46.96 Cr | -₹51.01 Cr | -₹47.76 Cr | -₹31 Cr | -₹27.65 Cr | -₹12.38 Cr | -₹8.07 Cr |
| Employee Benefit Expense | ₹92.85 Cr | ₹99.27 Cr | ₹100.13 Cr | ₹107.42 Cr | ₹96.47 Cr | ₹101.74 Cr | ₹98.81 Cr | ₹98.49 Cr | ₹99.42 Cr | ₹98.11 Cr | ₹96.72 Cr | ₹98.81 Cr |
| Finance Costs | ₹9.39 Cr | ₹7.42 Cr | ₹8.24 Cr | ₹6.54 Cr | ₹5.46 Cr | ₹6.75 Cr | ₹4.79 Cr | ₹4.03 Cr | ₹4.59 Cr | ₹5.58 Cr | ₹6.73 Cr | ₹5.76 Cr |
| Depreciation & Amortisation | ₹30.61 Cr | ₹31.25 Cr | ₹31.47 Cr | ₹31.79 Cr | ₹29.69 Cr | ₹30.54 Cr | ₹28.54 Cr | ₹28.33 Cr | ₹27.16 Cr | ₹27.86 Cr | ₹29.45 Cr | ₹28.77 Cr |
| Other Expenses | ₹166.57 Cr | ₹140.02 Cr | ₹142.27 Cr | ₹151.64 Cr | ₹142.44 Cr | ₹154.31 Cr | ₹131.34 Cr | ₹143.87 Cr | ₹140.04 Cr | ₹131.66 Cr | ₹147.34 Cr | ₹127.92 Cr |
| Total Expenses | ₹567.44 Cr | ₹515.06 Cr | ₹552.49 Cr | ₹542.44 Cr | ₹538.63 Cr | ₹484.86 Cr | ₹437.96 Cr | ₹435.3 Cr | ₹438.1 Cr | ₹429.7 Cr | ₹443.05 Cr | ₹429.7 Cr |
| Profit Before Exceptional Items & Tax | ₹31.15 Cr | ₹17.91 Cr | ₹47.44 Cr | -₹9.02 Cr | ₹57.8 Cr | ₹61.85 Cr | ₹32.99 Cr | ₹15 Cr | -₹24.6 Lakh | ₹15.95 Cr | -₹21.88 Cr | ₹2.12 Cr |
| Exceptional Items | -₹12.36 Cr | ₹275.52 Cr | -₹58.26 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹125.62 Cr | ₹68.01 Cr | ₹0 | ₹0 |
| Profit Before Tax | ₹18.79 Cr | ₹293.43 Cr | -₹10.82 Cr | -₹9.02 Cr | ₹57.8 Cr | ₹61.85 Cr | ₹32.99 Cr | ₹15 Cr | -₹125.87 Cr | ₹83.97 Cr | -₹21.88 Cr | ₹2.12 Cr |
| Total Tax Expense | ₹7.88 Cr | ₹29.14 Cr | ₹1.07 Cr | ₹1.45 Cr | ₹4.83 Cr | ₹4 Cr | ₹2.5 Cr | ₹5.74 Cr | ₹3.44 Cr | -₹2.22 Lakh | ₹2.61 Cr | ₹2.78 Cr |
| Net Profit | ₹10.91 Cr | ₹264.29 Cr | -₹11.89 Cr | -₹10.47 Cr | ₹52.97 Cr | ₹57.85 Cr | ₹30.49 Cr | ₹9.26 Cr | -₹129.31 Cr | ₹83.99 Cr | -₹24.49 Cr | -₹66.83 Lakh |
| attributable to Owners | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | - | ₹0 | ₹0 | - | ₹0 | - |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | - | ₹0 | ₹0 | - | ₹0 | - |
| Other Comprehensive Income | ₹9.16 Cr | -₹2.07 Cr | ₹1.85 Cr | ₹3.05 Cr | -₹6.27 Cr | ₹1.86 Cr | -₹2.82 Cr | ₹28.66 Lakh | -₹71.22 Lakh | -₹1.6 Cr | -₹64.81 Lakh | -₹2.51 Cr |
| Total Comprehensive Income | ₹20.07 Cr | ₹262.22 Cr | -₹10.04 Cr | -₹7.42 Cr | ₹46.7 Cr | ₹59.71 Cr | ₹27.67 Cr | ₹9.54 Cr | -₹130.02 Cr | ₹82.39 Cr | -₹25.14 Cr | -₹3.18 Cr |
| EBITDA (computed) | ₹71.15 Cr | ₹56.58 Cr | ₹87.15 Cr | ₹29.31 Cr | ₹92.95 Cr | ₹99.14 Cr | ₹66.32 Cr | ₹47.36 Cr | ₹31.5 Cr | ₹49.39 Cr | ₹14.3 Cr | ₹36.65 Cr |
| Basic EPS | ₹1.55 | ₹37.54 | ₹-1.69 | ₹-1.49 | ₹7.52 | ₹8.22 | ₹4.34 | ₹1.31 | ₹-18.37 | ₹11.93 | ₹-3.48 | ₹-0.09 |
| Diluted EPS | ₹1.55 | ₹37.47 | ₹-1.69 | ₹-1.49 | ₹7.50 | ₹8.19 | ₹4.32 | ₹1.31 | ₹-18.36 | ₹11.92 | ₹-3.48 | ₹-0.09 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,412.29 Cr | ₹1,735.7 Cr | ₹1,442.17 Cr | ₹1,072.43 Cr | ₹942.93 Cr | ₹1,123.97 Cr | ₹904.89 Cr |
| Other Income | ₹62.9 Cr | ₹40.83 Cr | ₹30.39 Cr | ₹41.85 Cr | ₹42.07 Cr | ₹47.37 Cr | ₹99.17 Cr |
| Total Income | ₹1,475.19 Cr | ₹1,776.53 Cr | ₹1,472.55 Cr | ₹1,114.28 Cr | ₹984.99 Cr | ₹1,171.34 Cr | ₹1,004.06 Cr |
| Cost of Materials Consumed | ₹671.59 Cr | ₹829.77 Cr | ₹716.92 Cr | ₹500.34 Cr | ₹434.92 Cr | ₹449.14 Cr | ₹400.21 Cr |
| Purchases of Stock-in-Trade | ₹1.05 Cr | ₹85 Lakh | ₹91.09 Lakh | ₹1.53 Cr | ₹1.35 Cr | ₹53.52 Lakh | ₹1.04 Cr |
| Changes in Inventories | -₹7.28 Cr | -₹33.33 Cr | -₹26.36 Cr | ₹22.01 Cr | -₹52.79 Cr | -₹16.73 Cr | -₹18.5 Cr |
| Employee Benefit Expense | ₹277.22 Cr | ₹287.51 Cr | ₹283.14 Cr | ₹270.86 Cr | ₹250.79 Cr | ₹234.04 Cr | ₹205.16 Cr |
| Finance Costs | ₹11.8 Cr | ₹7.62 Cr | ₹10.42 Cr | ₹9.38 Cr | ₹2.07 Cr | ₹1.3 Cr | ₹1.28 Cr |
| Depreciation & Amortisation | ₹119.03 Cr | ₹108.41 Cr | ₹105.46 Cr | ₹105.98 Cr | ₹83.19 Cr | ₹75.89 Cr | ₹71.09 Cr |
| Other Expenses | ₹419.35 Cr | ₹397.02 Cr | ₹416.63 Cr | ₹370.61 Cr | ₹352.21 Cr | ₹361.52 Cr | ₹407.58 Cr |
| Total Expenses | ₹1,492.76 Cr | ₹1,597.85 Cr | ₹1,507.13 Cr | ₹1,280.71 Cr | ₹1,071.74 Cr | ₹1,105.7 Cr | ₹1,067.87 Cr |
| Profit Before Exceptional Items & Tax | -₹17.57 Cr | ₹178.68 Cr | -₹34.57 Cr | -₹166.43 Cr | -₹86.75 Cr | ₹65.65 Cr | -₹63.81 Cr |
| Exceptional Items | ₹226.98 Cr | ₹4 Cr | -₹57.61 Cr | -₹112.66 Cr | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹209.41 Cr | ₹182.68 Cr | -₹92.18 Cr | -₹279.09 Cr | -₹86.75 Cr | ₹65.65 Cr | -₹63.81 Cr |
| Total Tax Expense | ₹50.47 Cr | ₹19.72 Cr | ₹0 | ₹20.61 Cr | -₹31.32 Cr | ₹11.56 Cr | -₹7.5 Cr |
| Net Profit | ₹158.94 Cr | ₹162.96 Cr | -₹92.18 Cr | -₹299.7 Cr | -₹55.43 Cr | ₹54.08 Cr | -₹56.32 Cr |
| Other Comprehensive Income | ₹7.6 Cr | ₹10 Lakh | -₹52.75 Lakh | ₹38.73 Cr | ₹55.37 Cr | ₹21.3 Cr | ₹3 Cr |
| Total Comprehensive Income | ₹166.54 Cr | ₹163.06 Cr | -₹92.71 Cr | -₹260.98 Cr | -₹5.76 Lakh | ₹75.39 Cr | -₹53.32 Cr |
| EBITDA (computed) | ₹113.26 Cr | ₹294.71 Cr | ₹81.31 Cr | -₹51.07 Cr | -₹1.49 Cr | ₹142.84 Cr | ₹8.56 Cr |
| Basic EPS | ₹22.57 | ₹23.15 | ₹-13.09 | ₹-42.57 | ₹-7.87 | ₹7.68 | ₹-8.00 |
| Diluted EPS | ₹22.53 | ₹23.08 | ₹-13.09 | ₹-42.57 | ₹-7.87 | ₹7.68 | ₹-8.00 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,092.45 Cr | ₹3,109.21 Cr | ₹2,863.7 Cr | ₹2,886.14 Cr |
| Non-current Assets | ₹1,555.55 Cr | ₹1,533.35 Cr | ₹1,454.22 Cr | ₹1,589.96 Cr |
| Current Assets | ₹1,533.65 Cr | ₹1,566.34 Cr | ₹1,406.13 Cr | ₹1,292.76 Cr |
| Property, Plant & Equipment | ₹1,182.15 Cr | ₹1,255.99 Cr | ₹1,164.94 Cr | ₹1,235.94 Cr |
| Inventories | ₹592.48 Cr | ₹584.06 Cr | ₹500.53 Cr | ₹480.19 Cr |
| Trade Receivables | ₹582.94 Cr | ₹748.14 Cr | ₹558.42 Cr | ₹472.08 Cr |
| Cash & Equivalents | ₹252.67 Cr | ₹60.58 Cr | ₹125.65 Cr | ₹155.67 Cr |
| Equity (Net Worth) | ₹2,627.1 Cr | ₹2,459.75 Cr | ₹2,294.63 Cr | ₹2,384.27 Cr |
| Equity Share Capital | ₹14.08 Cr | ₹14.08 Cr | ₹14.08 Cr | ₹14.08 Cr |
| Borrowings (Non-current) | ₹39.12 Cr | ₹60.81 Cr | ₹38.22 Cr | ₹63.65 Cr |
| Borrowings (Current) | ₹14.22 Cr | ₹50.24 Cr | ₹25.66 Cr | ₹38.03 Cr |
| Total Debt (computed) | ₹53.34 Cr | ₹111.05 Cr | ₹63.89 Cr | ₹101.68 Cr |
| Current Liabilities | ₹314.96 Cr | ₹519.53 Cr | ₹487.94 Cr | ₹388.66 Cr |
| Total Liabilities | ₹465.35 Cr | ₹649.46 Cr | ₹569.07 Cr | ₹501.87 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹52.6 Cr | ₹72.29 Cr | -₹41.57 Cr | -₹117.33 Cr | -₹158.31 Cr |
| Investing Cash Flow | ₹207.81 Cr | -₹132.07 Cr | ₹53.24 Cr | ₹202.5 Cr | ₹104.03 Cr |
| Financing Cash Flow | -₹70.66 Cr | -₹4.61 Cr | -₹48.06 Cr | -₹61.76 Cr | ₹95.8 Cr |
| Capital Expenditure | ₹118.6 Cr | ₹112.81 Cr | ₹20.37 Cr | ₹42.05 Cr | ₹126.56 Cr |
| Free Cash Flow (computed) | -₹66 Cr | -₹40.52 Cr | -₹61.94 Cr | -₹159.38 Cr | -₹284.87 Cr |
| Dividends Paid | ₹36 Lakh | ₹36 Lakh | ₹21.35 Lakh | ₹28.25 Cr | ₹28.36 Cr |
| Net Change in Cash | ₹192.09 Cr | -₹65.07 Cr | -₹30.02 Cr | ₹25.16 Cr | ₹41.53 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹356.24 Cr | ₹314.9 Cr | ₹356.9 Cr | ₹384.25 Cr | ₹461.24 Cr | ₹447.83 Cr | ₹436.88 Cr | ₹389.75 Cr | ₹399.24 Cr | ₹362.43 Cr | ₹333.83 Cr | ₹346.67 Cr |
| Other Income | ₹22.22 Cr | ₹15.03 Cr | ₹21.4 Cr | ₹4.25 Cr | ₹6.05 Cr | ₹18.93 Cr | ₹7.08 Cr | ₹8.77 Cr | ₹7.04 Cr | ₹9.94 Cr | ₹7.58 Cr | ₹5.83 Cr |
| Total Income | ₹378.46 Cr | ₹329.93 Cr | ₹378.3 Cr | ₹388.5 Cr | ₹467.29 Cr | ₹466.76 Cr | ₹443.96 Cr | ₹398.52 Cr | ₹406.28 Cr | ₹372.37 Cr | ₹341.41 Cr | ₹352.49 Cr |
| Cost of Materials Consumed | ₹149.98 Cr | ₹152.42 Cr | ₹165.31 Cr | ₹203.88 Cr | ₹220.8 Cr | ₹193.01 Cr | ₹215.64 Cr | ₹200.32 Cr | ₹189.37 Cr | ₹188.69 Cr | ₹166.88 Cr | ₹171.98 Cr |
| Purchases of Stock-in-Trade | ₹23 Lakh | ₹23 Lakh | ₹47 Lakh | ₹12 Lakh | ₹18 Lakh | ₹18 Lakh | ₹21 Lakh | ₹27.95 Lakh | ₹21.21 Lakh | ₹21.28 Lakh | ₹24.22 Lakh | ₹24.38 Lakh |
| Changes in Inventories | ₹12.1 Cr | -₹4.21 Cr | ₹6.91 Cr | -₹22.08 Cr | ₹1.88 Cr | ₹3.11 Cr | -₹12.68 Cr | -₹25.64 Cr | -₹2.12 Cr | -₹14.95 Cr | -₹4.84 Cr | -₹4.44 Cr |
| Employee Benefit Expense | ₹64.64 Cr | ₹69.88 Cr | ₹72.88 Cr | ₹72.86 Cr | ₹70.08 Cr | ₹73.04 Cr | ₹71.92 Cr | ₹72.47 Cr | ₹68.3 Cr | ₹71.16 Cr | ₹70.07 Cr | ₹73.61 Cr |
| Finance Costs | ₹4.09 Cr | ₹2.1 Cr | ₹3.68 Cr | ₹1.93 Cr | ₹1.53 Cr | ₹2.89 Cr | ₹1.82 Cr | ₹1.38 Cr | ₹1.76 Cr | ₹2.36 Cr | ₹3.82 Cr | ₹2.48 Cr |
| Depreciation & Amortisation | ₹28.97 Cr | ₹30.02 Cr | ₹30.11 Cr | ₹29.93 Cr | ₹27.47 Cr | ₹28.45 Cr | ₹26.39 Cr | ₹26.11 Cr | ₹25.22 Cr | ₹25.62 Cr | ₹27.26 Cr | ₹27.36 Cr |
| Other Expenses | ₹116.8 Cr | ₹95.19 Cr | ₹103.63 Cr | ₹103.73 Cr | ₹93.32 Cr | ₹104.28 Cr | ₹97.29 Cr | ₹102.13 Cr | ₹112.88 Cr | ₹98 Cr | ₹108.79 Cr | ₹96.96 Cr |
| Total Expenses | ₹376.81 Cr | ₹345.63 Cr | ₹382.99 Cr | ₹390.37 Cr | ₹415.26 Cr | ₹404.96 Cr | ₹400.59 Cr | ₹377.04 Cr | ₹395.63 Cr | ₹371.08 Cr | ₹372.22 Cr | ₹368.2 Cr |
| Profit Before Exceptional Items & Tax | ₹1.65 Cr | -₹15.7 Cr | -₹4.69 Cr | -₹1.87 Cr | ₹52.03 Cr | ₹61.8 Cr | ₹43.37 Cr | ₹21.48 Cr | ₹10.65 Cr | ₹1.29 Cr | -₹30.81 Cr | -₹15.7 Cr |
| Exceptional Items | -₹12.36 Cr | ₹275.52 Cr | -₹33.14 Cr | ₹0 | ₹4 Cr | ₹0 | ₹0 | ₹0 | -₹125.62 Cr | ₹68.01 Cr | ₹0 | ₹0 |
| Profit Before Tax | -₹10.71 Cr | ₹259.82 Cr | -₹37.83 Cr | -₹1.87 Cr | ₹56.03 Cr | ₹61.8 Cr | ₹43.37 Cr | ₹21.48 Cr | -₹114.97 Cr | ₹69.3 Cr | -₹30.81 Cr | -₹15.7 Cr |
| Total Tax Expense | ₹4.68 Cr | ₹43.71 Cr | ₹2.1 Cr | -₹2 Lakh | ₹4.81 Cr | ₹14.91 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹15.39 Cr | ₹216.11 Cr | -₹39.93 Cr | -₹1.85 Cr | ₹51.22 Cr | ₹46.89 Cr | ₹43.37 Cr | ₹21.48 Cr | -₹114.97 Cr | ₹69.3 Cr | -₹30.81 Cr | -₹15.7 Cr |
| Other Comprehensive Income | ₹2.65 Cr | ₹45 Lakh | ₹82 Lakh | ₹3.68 Cr | ₹1.41 Cr | -₹1.11 Cr | -₹80 Lakh | ₹60.38 Lakh | ₹44.83 Lakh | ₹32.5 Lakh | -₹1.12 Cr | -₹17.87 Lakh |
| Total Comprehensive Income | -₹12.74 Cr | ₹216.56 Cr | -₹39.11 Cr | ₹1.83 Cr | ₹52.63 Cr | ₹45.78 Cr | ₹42.57 Cr | ₹22.09 Cr | -₹114.52 Cr | ₹69.63 Cr | -₹31.93 Cr | -₹15.88 Cr |
| EBITDA (computed) | ₹34.71 Cr | ₹16.42 Cr | ₹29.1 Cr | ₹29.99 Cr | ₹81.03 Cr | ₹93.14 Cr | ₹71.58 Cr | ₹48.97 Cr | ₹37.63 Cr | ₹29.26 Cr | ₹27.45 Lakh | ₹14.14 Cr |
| Basic EPS | ₹-2.19 | ₹30.69 | ₹-5.67 | ₹-0.26 | ₹7.28 | ₹6.66 | ₹6.16 | ₹3.05 | ₹-16.33 | ₹9.85 | ₹-4.38 | ₹-2.23 |
| Diluted EPS | ₹-2.19 | ₹30.64 | ₹-5.67 | ₹-0.26 | ₹7.26 | ₹6.63 | ₹6.15 | ₹3.04 | ₹-16.33 | ₹9.85 | ₹-4.38 | ₹-2.23 |
Shareholding Pattern of Unichem Laboratories Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 70.22%, foreign institutional investors hold 1.00%, domestic institutional investors hold 10.63%, retail and other public shareholders hold 18.15% of Unichem Laboratories Limited. The company had 23,386 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% |
| Public | 29.78% | 29.78% | 29.78% | 29.78% | 29.78% | 29.78% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.22% | 70.22% | 70.22% | 50.93% | 50.93% | 50.93% | 50.74% | 50.64% | 50.67% | 50.08% | 50.10% |
| Public | 29.78% | 29.78% | 29.78% | 49.07% | 49.07% | 49.07% | 49.26% | 49.36% | 49.33% | 49.92% | 49.90% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | +19.29 | +0.00 | +0.00 | +0.19 | +0.10 | -0.03 | +0.59 | -0.02 | - |
Board & Governance of Unichem Laboratories Limited
As per the corporate governance filing with NSE for the quarter ended 31-DEC-2025, the board of Unichem Laboratories Limited has 6 directors - 3 independent and 1 executive. The board is chaired by Mody Prakash Amrut.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Mody Prakash Amrut | Non-Executive - Non Independent Director · Chairperson | 1974-06-22 | 1 |
| Pranay Godha | Non-Executive - Non Independent Director | 2023-08-10 | 2 |
| Pabitrakumar Kalipada Bhattacharyya | Executive Director | 2023-08-10 | 2 |
| Priti Puri | Non-Executive - Independent Director | 2023-03-21 | 1 |
| Arun Lalchand Todarwal | Non-Executive - Independent Director | 2024-02-05 | 4 |
| Anand Trimbak Kurse | Non-Executive - Independent Director | 2024-02-05 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Arun Lalchand Todarwal (Chairperson), Pabitrakumar Kalipada Bhattacharyya, Anand Trimbak Kurse, Priti Puri |
| Nomination and remuneration committee | Arun Lalchand Todarwal (Chairperson), Anand Trimbak Kurse, Priti Puri |
| Stakeholders Relationship Committee | Anand Trimbak Kurse (Chairperson), Pranay Godha, Pabitrakumar Kalipada Bhattacharyya, Priti Puri |
| Risk Management Committee | Arun Lalchand Todarwal (Chairperson), Pranay Godha, Pabitrakumar Kalipada Bhattacharyya, Anand Trimbak Kurse |
| Corporate Social Responsibility Committee | Arun Lalchand Todarwal (Chairperson), Pranay Godha, Pabitrakumar Kalipada Bhattacharyya |
Group Structure of Unichem Laboratories Limited
Unichem Laboratories Limited has 1 associated company. This group structure data is as of FY 2025. The corporate group structure reflects Unichem Laboratories Limited's business expansion strategy and organizational complexity.
Charges & Borrowings of Unichem Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2025 | Citi Bank N.A. | ₹30 Cr | Open |
| 24 Jan 2025 | Citi Bank N.A. | ₹51 Cr | Open |
| 04 Jan 2022 | Others | ₹30 Cr | Open |
| 31 May 2019 | Others | ₹125 Cr | Open |
| 28 Feb 2020 | Axis Bank Limited | ₹30 Cr | Satisfied |
Total charge records: 54 View all charges
Employees and EPFO Compliance at Unichem Laboratories Limited
Unichem Laboratories Limited has a workforce of 3,635 employees as of Sep 25, 2025.
Employee and EPFO history for Unichem Laboratories Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Unichem Laboratories Limited
GST registrations and filing compliance for Unichem Laboratories Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Unichem Laboratories Limited
Credit ratings, litigation, and regulatory alerts for Unichem Laboratories Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Unichem Laboratories Limited
MSME payment history for Unichem Laboratories Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Unichem Laboratories Limited
Corporate group structure for Unichem Laboratories Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Unichem Laboratories Limited
MCA filings and documents for Unichem Laboratories Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Unichem Laboratories Limited
Recent News on Unichem Laboratories Limited
Frequently Asked Questions about Unichem Laboratories Limited
Unichem Laboratories Limited is an active public limited company in the pharma sector based in Kandivali West, Maharashtra, India. It was incorporated on 22 August 1962 (64+ years old) and is registered under CIN L99999MH1962PLC012451. Listed on BSE: 506690 and NSE: UNICHEMLAB. The company has 3,635 employees.
Unichem Laboratories Limited reported revenue of ₹2,201.85 Cr for FY 2026 (up 4.31% YoY) based on consolidated NSE filings.
The current directors of Unichem Laboratories Limited are:
- Prakash Amrut Mody - Director
- Swati Arvind Patankar - Additional Director
- Arun Lalchand Todarwal - Director
- Anand Trimbak Kusre - Director
- Pranay Premchand Godha - Director
- Pabitrakumar Kalipada Bhattacharyya - Managing Director
The primary industry of Unichem Laboratories Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Unichem Laboratories Limited is listed on both BSE (code: 506690) and NSE (symbol: UNICHEMLAB).
Unichem Laboratories Limited can be reached at the registered office: 47 Kandivli Industrial Estate, Kandivali West, Maharashtra, India – 400067, or through the website unichemlabs.com.